Jon Borell Appointed as Member of SK Capital Executive Committee
Milestone
SK Capital Reaches Agreement to Sell Milestone Environmental to I Squared Capital
Apotex
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
Genetix
Genetix Biotherapeutics and SPIMACO Announce Strategic Agreement to Commercialize and Manufacture LYFGENIA™ & ZYNTEGLO™ in Saudi Arabia and the Broader Middle East Region
Apotex
Apotex Health Corp. Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full
Isolatek
SK Capital Completes the Sale of Isolatek International to Catchment Capital